Eiger BioPharmaceuticals Files for Bankruptcy
Wall Street Journal
Shares of Eiger BioPharmaceuticals plunged to an all-time low after the company filed for chapter 11 bankruptcy with a deal in hand to sell its Zokinvy drug.
https://www.wsj.com/articles/eiger-biopharmaceuticals-files-for-bankruptcy-c59be848